Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Human Tetra-Ubiquitin/Ub4 Non-hydrolyzable (Linear) Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ UCN710100

Catalog No. UCN710100

Item Discontinued This item has been discontinued by the supplier. Please to view product availability in your area.

This item is not returnable. View return policy

Description

Description

The Recombinant Human Linear Tetra-Ub Non-hydrolyzable is derived from E. coli. The Recombinant Human Linear Tetra-Ub Non-hydrolyzable has been validated for the following applications: Enzyme Activity.
Specifications

Specifications

P0CG47
7314
100μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Recombinant
Lyophilized from deionized water. Reconstitute at 2mg/mL in aqueous buffer.
Tetra-Ubiquitin/Ub4 Non-hydrolyzable (Linear)
E. coli-derived human Tetra-Ubiquitin protein Each Ubiquitin contains a Pro substitution at position 73
Unconjugated
95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain.
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit